China SXT Pharmaceuticals, Inc. (SXTC)

USD 2.28

(2.7%)

Operating Income Summary of China SXT Pharmaceuticals, Inc.

  • China SXT Pharmaceuticals, Inc.'s latest annual operating income in 2024 was -2.51 Million USD , up 55.15% from previous year.
  • China SXT Pharmaceuticals, Inc.'s latest quarterly operating income in 2024 FY was -2.09 Million USD , up 62.69% from previous quarter.
  • China SXT Pharmaceuticals, Inc. reported an annual operating income of -5.6 Million USD in 2023, down -8.05% from previous year.
  • China SXT Pharmaceuticals, Inc. reported an annual operating income of -5.18 Million USD in 2022, down -136.21% from previous year.
  • China SXT Pharmaceuticals, Inc. reported a quarterly operating income of -4.67 Million USD for 2024 Q1, down -4.88% from previous quarter.
  • China SXT Pharmaceuticals, Inc. reported a quarterly operating income of 3.41 Million USD for 2024 Q4, down 0.0% from previous quarter.

Annual Operating Income Chart of China SXT Pharmaceuticals, Inc. (2024 - 2016)

Historical Annual Operating Income of China SXT Pharmaceuticals, Inc. (2024 - 2016)

Year Operating Income Operating Income Growth
2024 -2.51 Million USD 55.15%
2023 -5.6 Million USD -8.05%
2022 -5.18 Million USD -136.21%
2021 -2.19 Million USD -151.28%
2020 4.28 Million USD 142.15%
2019 1.76 Million USD 8.41%
2018 1.63 Million USD 1.88%
2017 1.6 Million USD 666.08%
2016 209.14 Thousand USD 0.0%

Peer Operating Income Comparison of China SXT Pharmaceuticals, Inc.

Name Operating Income Operating Income Difference
ANI Pharmaceuticals, Inc. 46.97 Million USD 105.355%
Aquestive Therapeutics, Inc. -15.1 Million USD 83.345%
Collegium Pharmaceutical, Inc. 166.96 Million USD 101.506%
Cosmos Health Inc. -21.83 Million USD 88.479%
Cyclo Therapeutics, Inc. -20.05 Million USD 87.455%
Esperion Therapeutics, Inc. -155.56 Million USD 98.383%
Cronos Group Inc. -81.37 Million USD 96.909%
Incannex Healthcare Limited -30.04 Million USD 91.627%
Kala Pharmaceuticals, Inc. -39.15 Million USD 93.576%
Lifecore Biomedical, Inc. 9.33 Million USD 126.955%
Regencell Bioscience Holdings Limited -4.73 Million USD 46.9%
Sunshine Biopharma, Inc. -4.78 Million USD 47.439%
Sunshine Biopharma, Inc. -4.78 Million USD 47.439%
SCYNEXIS, Inc. 72.66 Million USD 103.461%
Safety Shot Inc -12.18 Million USD 79.357%
Theratechnologies Inc. -10.62 Million USD 76.332%
Alpha Teknova, Inc. -35.56 Million USD 92.927%
Universe Pharmaceuticals INC -3.52 Million USD 28.682%
Pacira BioSciences, Inc. 87.67 Million USD 102.869%
Sonoma Pharmaceuticals, Inc. -4.7 Million USD 46.496%
Dynavax Technologies Corporation -37.02 Million USD 93.207%
Ironwood Pharmaceuticals, Inc. 209.03 Million USD 101.203%
Radius Health, Inc. -3.92 Million USD 35.918%
Alvotech -354.86 Million USD 99.291%
Intra-Cellular Therapies, Inc. -159.38 Million USD 98.422%
SIGA Technologies, Inc. 83.62 Million USD 103.008%
Shineco, Inc. -17.06 Million USD 85.262%
Silver Spike Investment Corp. 7.34 Million USD 134.267%
Journey Medical Corporation -2.07 Million USD -21.332%
Petros Pharmaceuticals, Inc. -13.61 Million USD 81.529%
Embecta Corp. 221.5 Million USD 101.136%
Harrow Health, Inc. 580 Thousand USD 533.658%
Procaps Group, S.A. 38.97 Million USD 106.454%
Biofrontera Inc. -22.67 Million USD 88.909%
DURECT Corporation -36.88 Million USD 93.181%
PainReform Ltd. -9.58 Million USD 73.756%
Supernus Pharmaceuticals, Inc. -5.26 Million USD 52.264%
OptiNose, Inc. -22.74 Million USD 88.943%
RedHill Biopharma Ltd. 12.63 Million USD 119.911%
Organogenesis Holdings Inc. 12.52 Million USD 120.082%
Cumberland Pharmaceuticals Inc. -6.21 Million USD 59.503%
ProPhase Labs, Inc. -21.61 Million USD 88.362%
Phibro Animal Health Corporation 53.31 Million USD 104.718%
Procaps Group S.A. 52.32 Million USD 104.807%
TherapeuticsMD, Inc. -8.52 Million USD 70.489%
Viatris Inc. 766.2 Million USD 100.328%
Rockwell Medical, Inc. -6.67 Million USD 62.291%
Aytu BioPharma, Inc. -5.25 Million USD 52.128%
Tilray Brands, Inc. -174.74 Million USD 98.561%
PetIQ, Inc. 60.01 Million USD 104.191%
Talphera, Inc. -16.88 Million USD 85.107%
Neurocrine Biosciences, Inc. 250.9 Million USD 101.002%
Alimera Sciences, Inc. -1.47 Million USD -70.987%
Assertio Holdings, Inc. -243.53 Million USD 98.967%
Shuttle Pharmaceuticals Holdings, Inc. -5.89 Million USD 57.314%
Avadel Pharmaceuticals plc -137.84 Million USD 98.175%
Hempacco Co., Inc. -8.81 Million USD 71.458%
Alvotech -354.86 Million USD 99.291%
Lantheus Holdings, Inc. 364.64 Million USD 100.69%
Kamada Ltd. 10.06 Million USD 124.992%
Currenc Group, Inc. -6.64 Million USD 62.153%
Indivior PLC -4 Million USD 37.12%
Evoke Pharma, Inc. -7.43 Million USD 66.152%
Flora Growth Corp. -50.35 Million USD 95.005%
Cyclo Therapeutics, Inc. -20.05 Million USD 87.455%
Evolus, Inc. -49.23 Million USD 94.891%
HUTCHMED (China) Limited 18.37 Million USD 113.688%
Amphastar Pharmaceuticals, Inc. 196.98 Million USD 101.277%
Akanda Corp. -10.05 Million USD 74.976%